Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

CYTOSKELETON, INC

UEI: WCL9FJ3PGQL3CAGE: 3L6F0

CYTOSKELETON, INC is a federal contractor, registered under UEI WCL9FJ3PGQL3 and CAGE code 3L6F0. It has been awarded $19,959 across 19 federal contracts. Primary work spans Unknown NAICS and Biological Product (except Diagnostic) Manufacturing. Top awarding agencies include Department Of Veterans Affairs and Department Of Health And Human Services.

Contact Information

Registration and classification details

Websitehttps://www.cytoskeleton.com

Address123 Main St, City, ST 12345

Registration

UEI Code

WCL9FJ3PGQL3

CAGE Code

3L6F0

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

2X8WA2MF

NAICS Codes

325413In-Vitro Diagnostic Substance Manufacturing

325414Biological Product (except Diagnostic) Manufacturing(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

CYTOSKELETON, INC specializes in advanced biochemical research and development, with core capabilities centered on the design, synthesis, and characterization of novel cytoskeletal-targeted compounds and molecular probes. The company leverages deep expertise in cell biology, structural biochemistry,...

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Veterans Affairs$16.6K83.1%

Department Of Health And Human Services$3.4K16.9%

Awards by NAICS

- Unknown NAICS$16.6K83.1%

325414 - Biological Product (except Diagnostic) Manufacturing$3.4K16.9%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in CYTOSKELETON, INC's top NAICS codes and agencies

TEST KIT, BACTERIA D

Solicitation # SPE2DS-26-T-310W

The contract is for the procurement of 25 units of the API 20 E test kit, designed for the identification of Enterobacteriaceae and other gram-negative rods, under the NSN 6550-01-507-3726. Each purchase group (PG) equals 25 units, and the full order consists of exactly one PG. The product must be delivered within five days of contract award, with delivery terms specified as FOB destination, and no quantity variance is permitted. Strict shelf-life requirements apply: no more than three months may have elapsed from the date of manufacture to the date of delivery, and the item has a non-extendable shelf life of 18 months, classified as a TYPE I CODE K item. The test kits require refrigerated storage between 2 and 8 degrees Celsius at all times. Packaging must comply with commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with each unit sealed in protective containers and shipped in suitable exterior packaging to ensure safe delivery at the lowest freight rate. The product is regulated by the FDA, and the contracting official must submit a referral via EBS for confirmation, including manufacturer and part number details. The manufacturer is bioMérieux Inc with part number 20100. Technical and quality requirements are governed by the DLA Master List, and packaging, marking, and information security controls, including potential covered defense information, are mandated per applicable DLA directives. All documentation and compliance must align with the solicitation SPE2DS-26-T-310W, issued under NAICS code 325414 by the Department of Defense.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 7 hours ago

DEADLINE

DDDPlus Software Licensing and SupportThe contract entails the provision of five individual Standard licenses for DDDPlus software, covering full delivery, installation, and compatibility testing to ensure seamless integration with existing systems. License administration will be maintained throughout a four-year term, including ongoing support and compliance management. The work is performance-based with the place of performance located in Silver Spring, Maryland, under a subcontract structure, and falls under the NAICS code 511210 for software publishing. The Department of Health and Human Services is the contracting organization, with a response deadline set for August 14, 2026, and the solicitation was posted on August 4, 2026. All activities must align with federal procurement standards and deliverables must meet technical and operational requirements specified in the agreement.

Department Of Health And Human Services

POSTED

DEADLINE

GastroPlus Software Licensing and SupportThe contract awards the supply and ongoing support of 20 Standard licenses for GastroPlus software over a four-year period, encompassing full delivery, installation, and verification of compatibility with FDA systems. The provider is responsible for ensuring seamless integration into existing infrastructure and managing all aspects of license administration throughout the term. Performance is required to occur at the designated location in Silver Spring, Maryland, with the work falling under NAICS code 511210 for software publishing. The opportunity was posted on August 4, 2026, and responses are due by August 14, 2026, with the contracting entity being the Department of Health and Human Services. This subcontract supports critical regulatory and scientific operations that rely on GastroPlus for pharmacokinetic and pharmacodynamic modeling within federal health and safety contexts.

Department Of Health And Human Services

POSTED

DEADLINE

Custom Multi-Component Veterinary Drug Reference Standards (Sulfonamides)The contract involves the manufacture of two certified lots of multi-component sulfonamide reference standards for veterinary drug applications, each consisting of five 1mL ampules with precisely defined concentration ratios aligned to government-specified tables. The materials must be produced to meet stringent quality and stability requirements, including a minimum shelf life of 12 months at the time of shipment, ensuring long-term usability for regulatory and testing purposes. The standards are designated as ICV and CCV, indicating their use as independent calibration and control verification materials critical to analytical validation and compliance. The work is being procured by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with performance expected to occur in Denver, Colorado, and classified under NAICS code 325414 for pharmaceutical and botanical product manufacturing. Submission of proposals is due by August 7, 2026, and the contract is structured as a subcontract, suggesting it may follow an overarching government agreement. All output must adhere to exacting specifications to support federal laboratory and inspection protocols, with no flexibility permitted in composition, packaging, or stability validation.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Custom Multi-Component Veterinary Drug Reference Standards (NSAIDs)The contract entails the manufacture and delivery of ISO 17034-certified analytical reference standards specifically for nonsteroidal anti-inflammatory drugs (NSAIDs) to support veterinary drug residue testing. Two certified lots—intermediate control verification (ICV) and candidate control verification (CCV)—will be produced, each containing five 1mL glass ampules sealed for stability and purity. The reference standards are to be dissolved in LC-MS grade solvents to ensure compatibility with high-performance liquid chromatography and mass spectrometry workflows. All materials must meet rigorous certification standards to guarantee accuracy, traceability, and consistency in quantitative analytical applications. The work is required to be completed under a subcontract with a response deadline of August 7, 2026, and the place of performance is designated as Denver, Colorado, with a zip code of 80225. The contracting entity is the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, operating under NAICS code 325414, which corresponds to pharmaceutical preparation manufacturing. The deliverables are critical for laboratory quality control and regulatory compliance in animal health testing, requiring strict adherence to certification protocols and documentation without compromising sample integrity or analytical validity.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Intent to Sole Source - Endotoxin Detection System Cartridges

Solicitation # NOI-CC-OLAO-26-007979

The National Institute of Health, Clinical Center intends to sole source the purchase of proprietary endotoxin detection system cartridges from Charles River Laboratories to support the production and release of PET IND products. These cartridges are essential for bacterial endotoxin testing, ensuring all radiopharmaceuticals are pyrogen-free prior to patient administration, and are compatible only with the institution’s existing portable testing system. Due to the proprietary nature of the cartridges, no alternative suppliers can meet the technical requirements, justifying a sole source acquisition under 41 U.S.C. 253(c)(1) and FAR 6.302-1. The contract requires delivery of cartridges estimated at $22,200 by February 1, 2025, to prevent disruption in patient-ready product release; failure to meet this deadline would compromise the ability to conduct mandatory testing. A separate shipment for additional cartridges is also required by August 24, 2026, to sustain ongoing operations. This is not a request for proposal, but a notice of intent allowing other possible sources to submit capability statements by 12:00 PM Eastern Standard Time on August 7, 2026, to Valerie Gregorio at valerie.gregorio@nih.gov. All submissions received by the deadline will be evaluated, and the government retains full discretion to proceed without competition based on the responses.

National Institutes Of Health

POSTED

DEADLINE

Notice of Sole Source: GastroPlus PBPK and PBBM modeling platform subscription

Solicitation # 7571TE26Q00153

The U.S. Food and Drug Administration, through the Department of Health and Human Services, intends to sole-source a firm fixed-price contract to Simulations Plus Inc. for twenty GastroPlus and five DDDPlus software licenses, used for physiologically based pharmacokinetic and physiologically based biopharmaceutics modeling in support of generic drug research. The contract spans a base year from September 1, 2026, to August 31, 2027, with up to three one-year option periods extending through August 31, 2030. Performance will occur at the FDA’s White Oak campus in Silver Spring, Maryland. The acquisition is conducted under RFO 12, allowing for non-competitive procurement of commercial products, and no set-aside applies. Responses are due by August 14, 2026, and any interested party may submit a capability statement to demonstrate their ability to supply the exact software licenses as the original equipment manufacturer or authorized reseller, which the government will review solely to determine whether competitive procurement is warranted. The contract requires the vendor to provide standard individual licenses, with no auto-renewals permitted unless explicitly authorized. Acceptance of deliverables will be conducted by the Contracting Officer’s Representative within 30 working days of delivery, verifying software functionality, compatibility with FDA systems, and compliance with technical requirements. Invoicing must be submitted electronically through the Treasury’s Invoice Processing Platform, and all invoices must include detailed supporting documentation for labor, materials, and costs. The government retains the right to reject nonconforming deliveries and will not pay for services that fail to meet agreed standards. Clauses from the FAR and HHSAR govern payment, representation, whistleblower rights, anti-lobbying, accessibility, and dispute resolution, with federal regulations taking precedence over any vendor terms. The Contracting Officer and Contract Specialist are the primary points of contact, and all vendors must be actively registered in SAM at the time of submission.

Department Of Health And Human Services

POSTED

DEADLINE

Request for information - E60PH-28MPIV - Pandemic Influenza Vaccine Readiness and Supply Strategy

Solicitation # WS5703210526

Canada is seeking input from vaccine suppliers to inform its medium- and long-term strategy for ensuring readiness and supply of Pandemic Influenza Vaccine, with a target capacity to produce up to 110 million doses of a monovalent vaccine. This request for information aims to identify potential bidders capable of meeting the government’s needs for rapid, scalable vaccine production in the event of a pandemic, and to better understand industry capabilities, timelines, and conditions for fulfilling future contract opportunities. The initiative is led by the Department of Public Works and Government Services on behalf of the Government of Canada, with responses due by August 7, 2026, and all performance expected to take place within Canada. The NAICS code 325414 indicates the focus is on pharmaceutical and medicine manufacturing, and the sole point of contact for inquiries is Yessica Karnali Wijayaputri of SPAC/PSPC, reachable via email.

Department of Public Works and Government Services

POSTED

DEADLINE

QuantiFERON®-TB Gold Plus Reagent SupplyThe contract involves the supply of FDA-approved QuantiFERON-TB Gold Plus reagents designed for tuberculosis detection using the DiaSorin LIAISON XL instrument. This subcontract is issued by the Department of Veterans Affairs through the 257-NETWORK Contract Office 17, with performance required in Dallas, Texas, at ZIP code 75216. The reagents must meet stringent regulatory standards and be compatible with the specified diagnostic platform to ensure accurate and reliable results in clinical settings. The solicitation was posted on August 3, 2026, and responses are due by August 10, 2026, at 3:00 PM local time. The NAICS code 325414 identifies this as a business involved in the manufacturing of in vitro diagnostic substances. All reagents must be approved by the FDA and certified for use in tuberculosis screening programs within VA healthcare facilities.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

Unable to Decompose Subcontract OpportunitiesDue to a system error, the prime contract details necessary to identify or structure subcontract opportunities could not be retrieved, rendering all subcontracting analysis unavailable at this time. The solicitation is designated as a subcontract under the Department of Health and Human Services, with a posted date of August 3, 2026, and a response deadline of August 18, 2026. The place of performance is listed as Bethesda, Maryland, with a zip code of 20892, though no specific office address, point of contact, or set-aside information is provided. The NAICS code is marked as NA, and the agency and organizational designations are identical, indicating an internal system limitation. Despite the absence of actionable data for suppliers, the opportunity remains live in the system with a public view link available for reference.

Department Of Health And Human Services

POSTED

DEADLINE

Supply of Multi-Level Quality Controls – TRICONTROL

Great Plains Area Indian Health Svc

POSTED

DEADLINE

Reagent Supply – i-STAT CHEM8 Cartridges

Great Plains Area Indian Health Svc

POSTED

DEADLINE

Reagent Supply – i-STAT CG4 Cartridges

Great Plains Area Indian Health Svc

POSTED

DEADLINE

Antioxidant Therapy for Smith-Lemli-Opitz Syndrone

Solicitation # NICHD-08610

The contract pertains to the development and implementation of antioxidant therapy for Smith-Lemli-Opitz Syndrome, a rare genetic disorder characterized by multiple congenital anomalies and metabolic dysfunction. The solicitation, issued under NICHD-08610 by the Department of Health and Human Services through its National Institutes of Health, invites proposals aimed at advancing targeted antioxidant interventions to mitigate the pathological effects of the condition. The opportunity was posted on August 3, 2026, with responses due by August 18, 2026, at 2:00 PM Eastern Time. The work is expected to be performed in Bethesda, Maryland, consistent with the research infrastructure of the NIH campus. All proposals must be submitted through the SAM.gov portal and should address scientific rigor, feasibility, and potential clinical impact. The primary point of contact for inquiries is Niamh Cawley, with Chung Huang as the secondary contact, both reachable via NIH email addresses. The contracting activity falls under the Department of Health and Human Services with no set-aside provisions specified, and no NAICS code is assigned, indicating flexibility in contractor categorization. Interested parties should ensure adherence to deadlines and submission requirements outlined on the official UI link linked in the posting.

Department Of Health And Human Services

POSTED

DEADLINE

Medical Diagnostic Test Kit SupplyThe contract seeks the supply of ready-to-use Salmonella Identification Test Kits designed for rapid, accurate detection in medical and public health settings. All kits must include complete components necessary for deployment and operation, with strict adherence to applicable regulatory standards to ensure reliability, safety, and consistency across use environments. The testing technology must meet established performance criteria for sensitivity, specificity, and stability under operational conditions, with documentation to verify compliance with relevant quality and regulatory frameworks. The contract is issued as a subcontract under the Department of Defense’s Medical Supply Chain initiative, with performance requirements tied to the designated location in Williamsburg, Virginia, at zip code 23185-5830. The solicitation is open for responses until August 10, 2026, and is classified under NAICS code 325414, which covers the manufacturing of diagnostic substances. The contracting activity is managed by the MEDICAL SUPPLY CHAIN MD SURG FSF, and interested parties must submit proposals through the DIBBS platform prior to the deadline to be considered for award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Small Business Subcontract Participation (WOSB, SDVOSB, HUBZone)Certified small businesses including Women-Owned Small Businesses, Service-Disabled Veteran-Owned Small Businesses, and HUBZone concerns are invited to participate as subcontractors in supply, compliance, or logistics functions under a federal opportunity managed by the Department of Defense's Medical Supply Chain MD SURG FSF. This solicitation is tied to NAICS code 325414, indicating involvement in pharmaceutical and medicine manufacturing supply chain activities, and is specifically designed to foster small business engagement through subcontracting roles. The opportunity was posted on August 2, 2026, and responses are due by August 10, 2026, with no formal set-aside designation applied, allowing eligible small businesses to compete for subcontracting opportunities across the broader contract performance landscape. All participation must occur through the designated DIBBS platform linked in the solicitation, and while specific location details for performance are not provided, work will support Department of Defense medical supply needs.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Anesthesia Set SupplyThe contract entails the supply of complete epidural anesthesia kits, each comprising 29 precisely specified components, including a 20G epidural catheter and a 17G Tuohy needle featuring a winged design for enhanced handling and stability during insertion. The kits are intended for use in medical procedures requiring regional anesthesia and must meet strict quality and compatibility standards to ensure clinical safety and effectiveness. The solicitation is issued as a subcontract under the NAICS code 325414, which pertains to pharmaceutical and medicine manufacturing, and is managed by the Department of Defense through its Medical Supply Chain MD Surg FSF division. Responses are due by August 10, 2026, with the request published on August 2, 2026, providing potential suppliers a window of eight days to submit proposals. The place of performance and point of contact details are not specified, but all work is expected to align with Department of Defense procurement protocols and logistical requirements. The official solicitation can be accessed via the DIBBS platform for further technical specifications and submission guidelines.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Device Component Supply (6 mm Cannula and 60 cc Syringe)The contract requires the supply of sterile, medical-grade 6 mm cannulas and 60 cc syringes to be integrated into an aspiration kit, with all components meeting stringent FDA and military specifications to ensure safety, sterility, and regulatory compliance. These components are critical for use in field-deployed medical environments and must be manufactured and packaged to uphold the highest standards of quality and reliability under demanding operational conditions. The delivery must align with military logistics requirements, including packaging, labeling, and traceability protocols appropriate for DoD procurement. The solicitation is issued under the NAICS code 325414 for medical device manufacturing and is classified as a subcontract within the Department of Defense's Medical Supply Chain initiative. The place of performance is designated as APO 96264-2022, indicating delivery to a military postal address, likely for distribution to overseas or expeditionary medical units. The response deadline is set for August 10, 2026, with the solicitation posted on August 2, 2026, providing a seven-day window for qualified suppliers to submit proposals. No set-aside provisions are specified, meaning the opportunity is open to all eligible contractors capable of fulfilling the technical and regulatory demands.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE